Clinical isolates of ST131 blaOXA-244-positive Escherichia coli, Italy, December 2022 to July 2023

Aurora Piazza,Marta Corbella,Vittoria Mattioni Marchetti,Cristina Merla,Irene Mileto,Angela Kuka,Greta Petazzoni,Stefano Gaiarsa,Roberta Migliavacca,Fausto Baldanti,Patrizia Cambieri,Fausto Baldanti and Patrizia Cambieri
DOI: https://doi.org/10.2807/1560-7917.es.2024.29.8.2400073
2024-02-23
Eurosurveillance
Abstract:The dissemination of carbapenemase-producing Escherichia coli, although still at low level, should be continuously monitored. OXA-244 is emerging in Europe, mainly in E. coli . In Italy, this carbapenemase was reported from an environmental river sample in 2019. We report clinical isolates of OXA-244-producing ST131 E. coli in four patients admitted to an acute care hospital in Pavia, Italy. The association of this difficult-to-detect determinant with a globally circulating high-risk clone, ST131 E. coli, is of clinical relevance.
infectious diseases
What problem does this paper attempt to address?